Number of Employees
125
Revenue
$6.50 Million
Biopharmaceuticals
ProQR Therapeutics NV is a biopharmaceutical company founded in 2012 and engaged in the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders. ProQR Therapeutics’ Axiomer® technology enables the body to repair its own RNA specifically and reversibly. The company’s Antisense oligonucleotides (AONs) are designed to inhibit the expression of a target RNA, or adjust the splicing pattern of an RNA, in this way repairing the RNA and thereby allowing a functional protein to be produced. Initially the company focused on cystic fibrosis, but it eventually expanded to other diseases that can potentially be targeted using this proprietary platform technology.
Smital Shah
Daniel A. de Boer
Nice Insight/That’s Nice
89 Fifth AvenueFifth FloorNew YorkNY 10003-3020
New York – San Diego – ChicagoLondon – Frankfurt – Shanghai
Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.